MR. CHAN PENGEE, ADRIAN
Non-Executive Chairman; Independent Director
HC Surgical Specialists boardThe business, the people and the ownership behind HC Surgical.
Business overview
HC Surgical Specialists operates clinics and endoscopy centres in Singapore. Its services include gastroscopy, colonoscopy and general surgery, with a particular focus on colorectal surgery and procedures delivered through its network of specialist facilities.
Listed security
Board & management
Five current board members include Dr. Heah Sieu Min as CEO and Dr. Chia Kok Hoong as Medical Director. Two additional key management members are listed. Chong Weng Hoe stepped down as Chairman and Independent Director on 25 September 2025; his current role is Non-Independent Non-Executive Director.
Non-Executive Chairman; Independent Director
HC Surgical Specialists boardExecutive Director; Chief Executive Officer
HC Surgical Specialists boardExecutive Director; Medical Director
HC Surgical Specialists boardIndependent; Non-Executive Director
HC Surgical Specialists boardNon-Independent; Non-Executive Director
HC Surgical Specialists boardChief Financial Officer
HC Surgical Specialists key managementChief Operating Officer
HC Surgical Specialists key managementRoles listed in ANNUAL REPORT 2026; current appointments are not independently verified.
Holdings
Two substantial shareholders and twenty registered / depository holders as at 21 August 2026. The 153,375,507-share denominator excludes 2,934,400 treasury shares. The founders’ direct interests are expressly held through DBS Nominees and overlap with its registered position; they are not added to it.
Direct interest: 63,988,980(1) shares, 41.72%; deemed interest: – shares, –%.
Direct / deemed interests; shares held through DBS NomineesDirect interest: 34,753,440(2) shares, 22.66%; deemed interest: – shares, –%.
Direct / deemed interests; shares held through DBS NomineesTotal interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-08-21 · PDF p. 151
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| DBS NOMINEES PTE LTD | 103,014,420 shares; 67.16%. | PDF p. 1512026-08-21 | |
| YEO KHEE SENG BENNY | 6,839,309 shares; 4.46%. | PDF p. 1512026-08-21 | |
| MEDINEX LIMITED | 6,090,400 shares; 3.97%. | PDF p. 1512026-08-21 | |
| LIM WEI-MIN, JASON | 5,214,277 shares; 3.40%. | PDF p. 1512026-08-21 | |
| CITIBANK NOMINEES SINGAPORE PTE LTD | 3,436,384 shares; 2.24%. | PDF p. 1512026-08-21 | |
| LEO TING PING RONALD | 3,015,629 shares; 1.97%. | PDF p. 1512026-08-21 | |
| IFAST FINANCIAL PTE LTD | 1,554,681 shares; 1.01%. | PDF p. 1512026-08-21 | |
| NG HOCK KON | 1,400,000 shares; 0.91%. | PDF p. 1512026-08-21 | |
| APEX CAPITAL GROUP PTE LTD | 1,270,000 shares; 0.83%. | PDF p. 1512026-08-21 | |
| CHUA CHIN HENG ALAN | 1,156,000 shares; 0.75%. | PDF p. 1512026-08-21 | |
| PHILLIP SECURITIES PTE LTD | 1,077,584 shares; 0.70%. | PDF p. 1512026-08-21 | |
| LIM AH KAW@LIM LAN CHING | 850,000 shares; 0.55%. | PDF p. 1512026-08-21 | |
| UOB KAY HIAN PTE LTD | 628,600 shares; 0.41%. | PDF p. 1512026-08-21 | |
| LAI JIUNN HERNG | 600,555 shares; 0.39%. | PDF p. 1512026-08-21 | |
| ANG HAO YAO (HONG HAOYAO) | 538,000 shares; 0.35%. | PDF p. 1512026-08-21 | |
| LAI WENG KAY | 503,400 shares; 0.33%. | PDF p. 1512026-08-21 | |
| TEOU KEM ENG @TEOU KIM ENG | 500,000 shares; 0.33%. | PDF p. 1512026-08-21 | |
| ABN AMRO CLEARING BANK N.V. | 489,800 shares; 0.32%. | PDF p. 1512026-08-21 | |
| LAU HOOI KHENG NANCY | 473,500 shares; 0.31%. | PDF p. 1512026-08-21 | |
| LAI JUNXU | 448,000 shares; 0.29%. | PDF p. 1512026-08-21 | |
Group structure
Nineteen subsidiaries are in the audited year-end schedule; one associate and two joint ventures are disclosed separately. Countries in those schedules denote principal place of business, not an inferred place of incorporation. Company ownership and NCI percentages retain both original years.
Medical L & C Services has a genuine unprinted FY2026 NCI cell; the FY2025 NCI cell is a printed dash. Neither is filled with inferred zero.
The group structure diagram prints HC (Siglap) 30% and Medistar 70%, while the audited year-end Company schedule prints 80% and 85%. Both source disclosures are retained; the undated diagram is not used to replace audited figures.
NYK is a subsequent acquisition completed with consideration paid on 1 July 2026. JLES acquired an additional 15% of MDS on 11 June 2026, making it wholly owned by the Group. These disclosures are separate from 31 May ownership.
Healthcare Essentials is a joint venture despite 20% ownership, because board decisions require unanimous approval. It reports at 31 March; appropriate adjustments are made through 31 May.
| Company | Market | Ownership interest |
|---|---|---|
| Heah Sieu Min (Mt E) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Colorectal endoscopy and piles centre; 100; 100; –; – | |
| Heah Sieu Min (Bukit Batok) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Provide outpatient consultation services and procedures in the field of Colorectal Endoscopy practices; 100; 100; –; – | |
| CKH (Farrer Park) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; General, vein laser vascular and laparoscopy surgery and other health services; 100; 100; –; – | |
| HC (Siglap) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Specialised medical services (including day surgical centres)/ clinics and other general medical services; 80; 80; 20; 20 | |
| HC (TPY) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Specialised medical services (including day surgical centres)/other health services; 100; 100; –; – | |
| Malcolm Lim Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Clinics and other general medical services; 51; 51; 49; 49 | |
| LAI BEC Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Clinics and other general medical services; 51; 51; 49; 49 | |
| Hannah Medical Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Clinics and other general medical services; 100; 100; –; – | |
| HC (Hillford) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1032026-05-31 | Singapore; Specialised medical services (including day surgical centres)/ clinics and other general medical services; 100; 100; –; – | |
| HC (GM) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Specialised medical services (including day surgical centres)/ clinics and other general medical services; 100; 100; –; – | |
| KPO Endoscopy & Surgery Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services; 70; 70; 30; 30 | |
| Medical L & C Services Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services; 100; 100; not printed; – | |
| Medical Services @ Tampines Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services/medical shared services; 100; 100; –; – | |
| Jason Lim Endoscopy and Surgery Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Specialised medical services/clinics and other general medical services; 100; 100; –; – | |
| HC (Ming) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services; 100; 100; –; – | |
| HC (AMK) Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services; 100; 100; –; – | |
| GMH Endoscopy & Surgery Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services; 100; 100; –; – | |
| Medistar Services Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Clinics and other general medical services; 85; 85; 15; 15 | |
| Chirurgia Pte. Ltd.Principal place of business; Company FY2026 / FY2025; NCI FY2026 / FY2025PDF p. 1042026-05-31 | Singapore; Specialised medical services (including day surgical centres); 51; –; 49; – | |
| NYK Endoscopy and Digestive Centre Pte. Ltd.Acquisition after FY2026 year-end, consideration paid 1 July 2026; not a 31 May 2026 subsidiaryPDF p. 1502026-07-01 | Singapore; provision of endoscopic procedures; 51% | |
| Total Orthopaedics Pte. Ltd.Held by the Company; Group effective interest FY2026 / FY2025PDF p. 1102026-05-31 | Singapore; Clinics and other general medical services; 35; 35 | |
| Healthcare Essentials Pte. Ltd.Held by the Company; Group effective interest FY2026 / FY2025PDF p. 1132026-05-31 | Singapore; Retail sale of pharmaceutical and medical goods/general trading of medical supplies/management consultancy services; 20; 20 | |
| HC Orthopaedics & Surgical Centre Pte. Ltd.Held by the Company; Group effective interest FY2026 / FY2025PDF p. 1132026-05-31 | Singapore; Clinics and other general medical services; 50; 50 | |
| HC (Siglap)Original undated group structure diagram; differs from audited Company ownership schedulePDF p. 10 | 30% | |
| MedistarOriginal undated group structure diagram; differs from audited Company ownership schedulePDF p. 10 | 70% | |
| MDSJLES acquired the additional interest on 11 June 2026; year-end Company ownership remains 85%PDF p. 1502026-06-11 | Additional 15%; wholly owned subsidiary of the Group | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| MS. SOPHIA ONG | Chief Financial Officer | PDF p. 17 | |
| MS. MELISSA SUSANTIO | Chief Operating Officer | PDF p. 17 | |
| MS. LEE HUI THENG | Chief Nursing Officer | PDF p. 17 |
Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Chee & Heah Surgical Associates Pte. Ltd. | 576 S$'000 | FY2026 aggregate IPT value excluding transactions <S$100,000 and shareholders' mandate transactions; Associate of Dr. Heah Sieu Min (CEO) | PDF p. 65 |
| Farrer Park Holdings Pte. Ltd. | 216 S$'000 | FY2026 aggregate IPT value; Associate of Dr. Chia Kok Hoong (Executive Director and Medical Director) | PDF p. 65 |
| CH Hillford Investments Pte. Ltd. | 162 S$'000 | FY2026 aggregate IPT value; Associate of CKH | PDF p. 65 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dr. Heah Sieu Min | 1,122,926 S$ | FY2026, Executive Director/CEO total | PDF p. 55 |
| Dr. Chia Kok Hoong | 637,248 S$ | FY2026, Executive Director total | PDF p. 55 |
| Mr. Chong Weng Hoe | 39,000 S$ | FY2026, Non-Executive Director fee total | PDF p. 55 |
| S$250,001 to S$500,000 | Ms. Sophia Ong | FY2026 Key Management Personnel (not Directors or CEO), bands of S$250,000 | PDF p. 56 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Acquisition of subsidiary - NYK Endoscopy and Digestive Centre Pte. Ltd. (“NYK”) | On 8 June 2026, the Company entered into a sale and purchase agreement to acquire 51% of the issued and fully paid-up capital in NYK. | Events subsequent to reporting date (31 May 2026) · As at 2026-06-08 | PDF p. 150 |
| Transaction with NCI | On 11 June 2026, JLES had completed the acquisition of an additional 15% of the issued and fully paid up shares in MDS. | Events subsequent to reporting date (31 May 2026) · As at 2026-06-11 | PDF p. 150 |
Extracted from ANNUAL REPORT 2026 and checked against the cited pages; see the original report for full context.
Corporate information